These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 16914468)

  • 1. Interleukin 10 and transforming growth factor beta contribute to the development of experimentally induced allergic conjunctivitis in mice during the effector phase.
    Fukushima A; Sumi T; Fukuda K; Kumagai N; Nishida T; Yagita H; Ueno H
    Br J Ophthalmol; 2006 Dec; 90(12):1535-41. PubMed ID: 16914468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Participation of CD11b and F4/80 molecules in the conjunctival eosinophilia of experimental allergic conjunctivitis.
    Fukushima A; Ishida W; Ojima A; Kajisako M; Sumi T; Yamada J; Tsuru E; Miyazaki J; Tominaga A; Yagita H
    Int Arch Allergy Immunol; 2010; 151(2):129-36. PubMed ID: 19752566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of OX40 in the development of murine experimental allergic conjunctivitis: exacerbation and attenuation by stimulation and blocking of OX40.
    Fukushima A; Yamaguchi T; Ishida W; Fukata K; Yagita H; Ueno H
    Invest Ophthalmol Vis Sci; 2006 Feb; 47(2):657-63. PubMed ID: 16431965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of VLA-4 in the development of allergic conjunctivitis in mice.
    Fukushima A; Yamaguchi T; Ishida W; Fukata K; Ueno H
    Mol Vis; 2006 Apr; 12():310-7. PubMed ID: 16617298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous interleukin-10 produced by antigen-irrelevant cells promotes the development of experimental murine allergic conjunctivitis.
    Fukushima A; Sumi T; Fukuda K; Kumagai N; Nishida T; Ueno H
    Int Arch Allergy Immunol; 2007; 144(1):79-84. PubMed ID: 17505142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous IL-17 does not play a significant role in the development of experimental murine allergic conjunctivitis.
    Fukushima A; Sumi T; Ishida W; Yamada J; Iwakura Y; Ueno H
    Int Arch Allergy Immunol; 2008; 147(3):206-12. PubMed ID: 18594150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with FTY720 during the induction or effector phase suppresses the development of experimental allergic conjunctivitis in mice.
    Sumi T; Fukushima A; Nishino K; Fukuda K; Kumagai N; Nishida T; Ueno H
    Cell Biol Int; 2009 Apr; 33(4):534-41. PubMed ID: 19230848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic overexpression of IFN-gamma and IL-5 exacerbates early phase reaction and conjunctival eosinophilia, respectively, in experimental allergic conjunctivitis.
    Ishida W; Tsuru E; Tominaga A; Miyazaki JI; Higuchi T; Sakamoto S; Fukushima A
    Br J Ophthalmol; 2009 Dec; 93(12):1680-5. PubMed ID: 19692377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Notch ligand Delta-like4 inhibits the development of murine experimental allergic conjunctivitis.
    Fukushima A; Sumi T; Ishida W; Ojima A; Kajisako M; Koyanagi A; Koyama N; Yagita H
    Immunol Lett; 2008 Dec; 121(2):140-7. PubMed ID: 19027794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of galectin-9 in the development of experimental allergic conjunctivitis in mice.
    Fukushima A; Sumi T; Fukuda K; Kumagai N; Nishida T; Okumura K; Akiba H; Yagita H; Ueno H
    Int Arch Allergy Immunol; 2008; 146(1):36-43. PubMed ID: 18087160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory T cells participate in 4-1BB-mediated suppression of experimental allergic conjunctivitis.
    Sumi T; Ishida W; Mittler RS; Yagita H; Taguchi O; Fukushima A
    Int Arch Allergy Immunol; 2009; 148(4):305-10. PubMed ID: 19001790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential modulation of allergic eye disease by chronic and acute ascaris infection.
    Schopf L; Luccioli S; Bundoc V; Justice P; Chan CC; Wetzel BJ; Norris HH; Urban JF; Keane-Myers A
    Invest Ophthalmol Vis Sci; 2005 Aug; 46(8):2772-80. PubMed ID: 16043850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral administration of Ag suppresses Ag-induced allergic conjunctivitis in mice: critical timing and dose of Ag.
    Ishida W; Fukuda K; Harada Y; Sumi T; Taguchi O; Tsuda M; Yagita H; Fukushima A
    Br J Ophthalmol; 2013 Apr; 97(4):492-7. PubMed ID: 23343653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of programmed death-ligand 2 (PD-L2) in the development of experimental allergic conjunctivitis in mice.
    Fukushima A; Yamaguchi T; Azuma M; Yagita H; Ueno H
    Br J Ophthalmol; 2006 Aug; 90(8):1040-5. PubMed ID: 16613922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B and T lymphocyte attenuator regulates the development of antigen-induced experimental conjunctivitis.
    Ishida W; Fukuda K; Kajisako M; Sumi T; Matsuda H; Yagita H; Fukushima A
    Graefes Arch Clin Exp Ophthalmol; 2012 Feb; 250(2):289-95. PubMed ID: 21779950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of interferon-gamma in a mouse model of allergic conjunctivitis.
    Stern ME; Siemasko K; Gao J; Duong A; Beauregard C; Calder V; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3239-46. PubMed ID: 16123425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD27 and CD70 do not play a critical role in the development of experimental allergic conjunctivitis in mice.
    Sumi T; Ishida W; Ojima A; Kajisako M; Sakanishi T; Yagita H; Fukushima A
    Immunol Lett; 2008 Aug; 119(1-2):91-6. PubMed ID: 18579220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin E receptor subtype EP3 in conjunctival epithelium regulates late-phase reaction of experimental allergic conjunctivitis.
    Ueta M; Matsuoka T; Narumiya S; Kinoshita S
    J Allergy Clin Immunol; 2009 Feb; 123(2):466-71. PubMed ID: 18996575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of tumour-necrosis factor-related apoptosis-inducing ligand receptor enhances the severity of murine allergic conjunctivitis.
    Sumi T; Ishida W; Okumura K; Yagita H; Fukushima A
    Br J Ophthalmol; 2009 Jan; 93(1):110-5. PubMed ID: 18782797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The immunization protocol determines whether endogenous interferon-gamma suppresses the infiltration of eosinophils into the conjunctiva.
    Fukushima A; Yamaguchi T; Ishida W; Fukata K; Ozaki A; Ueno H
    Immunol Lett; 2005 Sep; 100(2):189-94. PubMed ID: 15919119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.